Nvidias Annual Spending on Taiwan AI Suppliers Could Reach 150 Billion Says Jensen Huang Marvell Technology Stock Dips Despite Exceptional AI Demand Driving Accelerating Revenue Growth Outlook UK Bank Holiday Travel Disruptions and Record Heat May Influence Tourism Transport and Retail Sectors China Urges APEC Cooperation as Trade Minister Steps In for Commerce Minister on Urgent Business Fed Rate Hike Odds Surge as Hot Inflation Data Reshapes Market Expectations Indias Labor Market Under Strain as Iran Conflict Disrupts Remittances and Trade FTAIM Q1 2026 Earnings EPS Misses Estimates as Preferred Shares Deliver Mixed Results Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Ares Management ARES Q1 2026 Earnings EPS Misses Street View but Stock Gains on Resilient Business Trends Certara Q1 2026 Earnings EPS Misses Estimates but Stock Gains 135 BWFG Q1 2026 Earnings EPS Surpasses Estimates by 13 RLMD Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment Atour Lifestyle Holdings ATAT Slips 545 Key Support Levels Come into Focus Wingstop Inc WING Rallies 585 as Shares Test Key Resistance Brookfield Business Corporation BBUC Holds Steady Near Resistance After Modest Gain Spring Valley Acquisition Corp III Unit SVACU Edges Higher as Trading Activity Remains Steady Biodexa Pharmaceuticals BDRX Extends Gains Testing Key Resistance at 344 US Stock Futures and Bond Yields Decline After Reports of Updated Russian Nuclear Doctrine The Front Row at the Indy 500 Prime Real Estate with Financial Rewards Analysts Reassess Pinterest Incs Growth Prospects Amid Digital Advertising Shift US Prioritizes AI Integration in Asia Following TrumpXi Summit Canadian Big Banks Poised for Solid Q2 Results but Cautious Outlook Amid Soft Economic Backdrop Dekiln Partners with Johnson Tiles for Pilot Production of KilnFree Recycled Tiles Elon Musks OpenAI Attack Viewed as Competitive Strategy to Boost xAI HLMN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Inhibikase Therapeutics IKT Recovers 35 as Buyers Defend Key Support Level